Twenty drug pairs have landed on the interaction desk. For each, say whether there is a clinically significant interaction, what causes it, what happens to the patient, and what to do.
Some of these pairs have no meaningful interaction. Some are widely believed to interact and do not. Say so when that is the case. Do not manufacture a mechanism to fill a field.
[1] id=a41f warfarin + fluconazole 150 mg [2] id=7c02 simvastatin 40 mg + clarithromycin [3] id=b9d5 linezolid + sertraline [4] id=3e18 sildenafil + isosorbide mononitrate [5] id=c6a7 lisinopril + spironolactone [6] id=2f4b methotrexate 15 mg weekly + trimethoprim-sulfamethoxazole [7] id=8d31 clopidogrel + omeprazole [8] id=5a9e clopidogrel + pantoprazole [9] id=f072 rifampin + combined oral contraceptive [10] id=1b6c amoxicillin + combined oral contraceptive [11] id=e3f9 amiodarone + digoxin [12] id=94a2 lithium + ibuprofen [13] id=6d70 allopurinol + azathioprine [14] id=0c85 ciprofloxacin + tizanidine [15] id=a7be carbamazepine + apixaban [16] id=d218 colchicine + clarithromycin [17] id=4f63 ibuprofen 400 mg three times daily + aspirin 81 mg for secondary prevention [18] id=b5cd sacubitril/valsartan + lisinopril [19] id=27ea metformin + intravenous iodinated contrast [20] id=ec46 phenelzine + pseudoephedrine
Assume adults with normal renal and hepatic function unless the pair itself implies otherwise.
significant is true only if the pair changes what you would prescribe, dose, monitor, or warn the patient about. A theoretical interaction nobody acts on is false.mechanism is the specific pharmacology in one phrase — the enzyme, the transporter, the receptor, the additive effect. Not "drug interaction" and not "altered metabolism". Use "none" when significant is false.effect is what happens to the patient. Name the clinical event, not the direction of a serum level alone.action is what you do about it. Name the alternative drug, the dose change, the monitoring interval, or the separation in hours. "Use with caution" is not an action.numbers is an array of every exact number needed to carry out the action: a dose or dose fraction, a washout or separation time, a monitoring interval, or a threshold that changes the plan. Copy the number with enough context to show what it controls. Use an empty array only when the row has no such number. A number already printed in the pair does not count unless it is also part of the action.note is yours. Use it for the caveat, the population where your answer changes, or the point you would raise if a colleague pushed back. One or two sentences. Leave it as an empty string if you have nothing to add.Raw JSON, nothing else. No markdown fence, no preamble, no commentary after.
{
"rows": [
{ "id": "...", "significant": true, "mechanism": "...", "effect": "...", "action": "...", "numbers": ["..."], "note": "..." }
]
}
Keys in that order. significant is a boolean, not a string.
{ "rows": [ { "id": "a41f", "significant": true, "mechanism": "fluconazole inhibits CYP2C9 (and CYP3A4), reducing warfarin metabolism", "effect": "Elevated INR with bleeding risk, even with intermittent 150 mg dosing", "action": "Check INR within 3-5 days of starting fluconazole and after any re-dose; reduce warfarin dose if INR rises", "numbers": ["INR check within 3-5 days"], "note": "The 150 mg weekly dose is not low enough to ignore this; single-dose fluconazole for vaginitis can still push a sensitive INR." }, { "id": "7c02", "significant": true, "mechanism": "clarithromycin strongly inhibits CYP3A4, blocking simvastatin metabolism", "effect": "Markedly raised simvastatin exposure with myopathy and rhabdomyolysis risk", "action": "Suspend simvastatin for the duration of clarithromycin therapy, or use a statin not dependent on CYP3A4 such as rosuvastatin or pravastatin", "numbers": [], "note": "Short clarithromycin courses can be covered by holding the statin; this is the pragmatic choice for most patients." }, { "id": "b9d5", "significant": true, "mechanism": "linezolid is a weak nonselective MAO inhibitor; additive with sertraline's serotonergic effect", "effect": "Serotonin syndrome — agitation, hyperreflexia, hyperthermia", "action": "Avoid the combination; if linezolid is essential, hold sertraline and monitor for serotonergic signs during linezolid therapy and for 2 weeks after in susceptible patients", "numbers": ["2 weeks monitoring after linezolid"], "note": "Citalopram or escitalopram are somewhat lower-risk SSRIs but not risk-free; alternatives to linezolid (e.g., dalbavancin) are often the cleaner solution." }, { "id": "3e18", "significant": true, "mechanism": "additive nitric oxide/cGMP-mediated vasodilation", "effect": "Profound hypotension, syncope, possible cardiac ischemia", "action": "Contraindicated — do not co-prescribe; sildenafil must be washed out 24 hours before any nitrate is given for chest pain", "numbers": ["24 hours sildenafil washout before nitrate"], "note": "Patients on daily nitrates effectively cannot use PDE5 inhibitors at all; this needs explicit counseling, not just a pharmacy flag." }, { "id": "c6a7", "significant": true, "mechanism": "additive effects on potassium handling — ACE inhibition lowers aldosterone and spironolactone blocks the mineralocorticoid receptor", "effect": "Hyperkalemia, with risk of arrhythmia", "action": "Check serum potassium and renal function within 1-2 weeks of starting or changing either dose, then periodically", "numbers": ["potassium check within 1-2 weeks"], "note": "Risk rises sharply with reduced eGFR, diabetes, or older age despite the normal-baseline assumption; monitor tighter in those groups." }, { "id": "2f4b", "significant": true, "mechanism": "TMP-SMX is an antifolate that also competes with methotrexate for renal tubular secretion and displaces it from protein binding", "effect": "Severe pancytopenia and mucositis from amplified antifolate toxicity", "action": "Avoid TMP-SMX; choose an alternative antibiotic (e.g., nitrofurantoin or a cephalosporin per indication)", "numbers": [], "note": "Even low-dose weekly MTX interacts; the combination has caused fatal myelosuppression. Pneumocystis prophylaxis alternatives should be discussed before starting MTX, not after." }, { "id": "8d31", "significant": true, "mechanism": "omeprazole inhibits CYP2C19, reducing clopidogrel activation to its active metabolite", "effect": "Reduced antiplatelet effect; possible increase in thrombotic events", "action": "Switch the proton pump inhibitor to pantoprazole", "numbers": [], "note": "Pharmacokinetic interaction is real; clinical outcome data (e.g., COGENT) suggest modest risk, but since a zero-cost equivalent alternative exists, switching is standard practice." }, { "id": "5a9e", "significant": false, "mechanism": "none", "effect": "none", "action": "No action needed", "numbers": [], "note": "Pantoprazole is the weakest CYP2C19 inhibitor of the PPIs and is the standard pairing with clopidogrel." }, { "id": "f072", "significant": true, "mechanism": "rifampin is a potent inducer of CYP3A4 and of hepatic/intestinal estrogen metabolism", "effect": "Contraceptive failure — unintended pregnancy and breakthrough bleeding", "action": "Use a non-hormonal or non-interacting method (copper IUD, progestin implant or injection with caution) for the full course and for 4 weeks after stopping rifampin", "numbers": ["4 weeks backup contraception after rifampin stops"], "note": "Combined pills are effectively unreliable for the entire tuberculosis treatment course, which is usually months." }, { "id": "1b6c", "significant": false, "mechanism": "none", "effect": "none", "action": "No action needed", "numbers": [], "note": "The antibiotic-OC failure myth applies to enzyme inducers like rifampin, not amoxicillin; GI upset is the only theoretical concern and does not warrant backup contraception." }, { "id": "e3f9", "significant": true, "mechanism": "amiodarone inhibits P-glycoprotein, reducing renal and biliary clearance of digoxin", "effect": "Digoxin toxicity — nausea, visual disturbance, arrhythmias", "action": "Reduce the digoxin dose by approximately 50% when starting amiodarone and monitor digoxin levels and for toxicity", "numbers": ["reduce digoxin dose by 50%"], "note": "Interaction develops over days to weeks as amiodarone accumulates; check levels about 1-2 weeks after initiation, not just at day 1." }, { "id": "94a2", "significant": true, "mechanism": "NSAID reduces renal prostaglandins, decreasing lithium clearance", "effect": "Rising lithium levels with tremor, confusion, and lithium toxicity", "action": "Avoid ibuprofen — use acetaminophen; if an NSAID is unavoidable, reduce lithium dose (often by 25-40%) and recheck a lithium level within about 5-7 days", "numbers": ["reduce lithium dose by 25-40%", "lithium level within 5-7 days"], "note": "Celecoxib also raises lithium; acetaminophen is the safe analgesic choice for lithium patients." }, { "id": "6d70", "significant": true, "mechanism": "allopurinol inhibits xanthine oxidase, blocking conversion of azathioprine to 6-MU and shunting it to 6-thioguanine nucleotides", "effect": "Profound myelosuppression — neutropenia, pancytopenia", "action": "Reduce azathioprine dose to 25-33% of the usual dose when co-prescribed, and monitor CBC", "numbers": ["reduce azathioprine to 25-33% of usual dose"], "note": "The dose cut is mandatory, not optional — full-dose combination has caused fatal marrow failure." }, { "id": "0c85", "significant": true, "mechanism": "ciprofloxacin inhibits CYP1A2, blocking tizanidine clearance", "effect": "Markedly elevated tizanidine levels causing severe hypotension and sedation", "action": "Contraindicated — do not co-prescribe; use an alternative antibiotic that does not inhibit CYP1A2 (e.g., a cephalosporin) or discontinue tizanidine for the antibiotic course", "numbers": [], "note": "Fluvoxamine is the other classic 1A2-inhibitor to watch for; levofloxacin is a weaker 1A2 inhibitor but still not a preferred partner." }, { "id": "a7be", "significant": true, "mechanism": "carbamazepine is a strong inducer of CYP3A4 and P-glycoprotein, increasing apixaban clearance", "effect": "Subtherapeutic apixaban levels with stroke risk in atrial fibrillation", "action": "Avoid the combination — use an anticoagulant unaffected by strong induction (warfarin with INR monitoring) or an alternative anticonvulsant (levetiracetam)", "numbers": [], "note": "Effect persists for 1-2 weeks after stopping carbamazepine, so apixaban cannot simply be restarted immediately." }, { "id": "d218", "significant": true, "mechanism": "clarithromycin inhibits CYP3A4 and P-glycoprotein, blocking colchicine clearance", "effect": "Colchicine toxicity — GI symptoms, neuromyotoxicity, marrow suppression", "action": "Avoid clarithromycin; use an alternative antibiotic (azithromycin), and for treatment courses that must overlap, limit colchicine to a single 0.6 mg dose then 0.3 mg", "numbers": ["colchicine single 0.6 mg dose then 0.3 mg if unavoidable"], "note": "Contraindicated outright in renal or hepatic impairment; azithromycin gives gram-positive coverage without 3A4 inhibition." }, { "id": "4f63", "significant": true, "mechanism": "ibuprofen competes for the aspirin acetylation site on COX-1 in platelets, blocking aspirin's irreversible antiplatelet effect", "effect": "Loss of cardioprotection with increased myocardial infarction risk in secondary prevention", "action": "Take the 81 mg aspirin at least 2 hours before ibuprofen (or 8 hours after), or substitute acetaminophen/naproxen if analgesia is needed regularly", "numbers": ["aspirin at least 2 hours before ibuprofen", "8 hours after ibuprofen"], "note": "A single properly timed daily dose of ibuprofen is probably acceptable, but chronic multi-dose ibuprofen plus aspirin defeats the aspirin entirely." }, { "id": "b5cd", "significant": true, "mechanism": "additive RAAS blockade (ACE inhibition plus neprilysin inhibition/ARB) plus concurrent ACE inhibitor with neprilysin inhibition raises bradykinin", "effect": "Angioedema and severe hypotension", "action": "Contraindicated — do not use together; require a 36-hour washout when switching from lisinopril to sacubitril/valsartan", "numbers": ["36 hours washout between ACE inhibitor and sacubitril/valsartan"], "note": "The 36-hour rule exists specifically because of angioedema risk from overlapping bradykinin effects." }, { "id": "27ea", "significant": false, "mechanism": "none", "effect": "none", "action": "No action needed with normal renal function", "numbers": [], "note": "Contrast-induced AKI triggering metformin accumulation only matters when renal function is impaired — hold metformin for 48 hours with reassessment of renal function if eGFR is below 30, or below 60 with intra-arterial contrast or other AKI risks." }, { "id": "ec46", "significant": true, "mechanism": "MAO inhibition prevents metabolism of the indirect sympathomimetic pseudoephedrine", "effect": "Hypertensive crisis with risk of intracranial hemorrhage and arrhythmia", "action": "Contraindicated — avoid pseudoephedrine entirely in MAOI-treated patients; wait 14 days after stopping phenelzine before using sympathomimetics", "numbers": ["14 days washout after phenelzine"], "note": "Warn against OTC decongestants specifically; patients do not perceive them as drugs. Phenylephrine carries the same risk." } ] }